Targeting TCTP as a New Therapeutic Strategy in Castration-resistant Prostate Cancer

Heat shock protein 27 (Hsp27) is highly overexpressed in castration-resistant prostate cancer (CRPC) and an antisense inhibitor (OGX-427) is currently in phase II clinical trials. In order to understand mechanisms of action of Hsp27 and find new therapeutic targets specific of CRPC, we screened for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Baylot, Virginie, Katsogiannou, Maria, Andrieu, Claudia, Taieb, David, Acunzo, Julie, Giusiano, Sophie, Fazli, Ladan, Gleave, Martin, Garrido, Carmen, Rocchi, Palma
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2012
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3519986/
https://ncbi.nlm.nih.gov/pubmed/22893039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2012.155
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados